Marc R. Schneebaum
2020
In 2020, Marc R. Schneebaum earned a total compensation of $2.9M as Former Senior Vice President, Chief Financial Officer at Synta Pharmaceuticals, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,233 |
|---|---|
| Option Awards | $2,219,840 |
| Salary | $435,000 |
| Other | $18,399 |
| Total | $2,940,472 |
Schneebaum received $2.2M in option awards, accounting for 75% of the total pay in 2020.
Schneebaum also received $267.2K in non-equity incentive plan, $435K in salary and $18.4K in other compensation.
Rankings
In 2020, Marc R. Schneebaum's compensation ranked 3,936th out of 13,090 executives tracked by ExecPay. In other words, Schneebaum earned more than 69.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,936 out of 13,090 | 70th |
Division Manufacturing | 1,572 out of 5,621 | 72nd |
Major group Chemicals And Allied Products | 593 out of 2,254 | 74th |
Industry group Drugs | 511 out of 1,954 | 74th |
Industry Pharmaceutical Preparations | 387 out of 1,459 | 74th |
Source: SEC filing on May 2, 2022.
Schneebaum's colleagues
We found four more compensation records of executives who worked with Marc R. Schneebaum at Synta Pharmaceuticals in 2020.